期刊文献+

中药微调三号方联合香菇多糖对中晚期胃癌患者细胞免疫功能的影响 被引量:1

Effect of combination of traditional Chinese medicine and lentinan on cellular immunity in patients with medium and advanced gastric cancer
下载PDF
导出
摘要 目的观察中药微调三号方联合香菇多糖对中晚期胃癌患者细胞免疫功能的影响。方法将47例中晚期胃癌患者随机分为2组,中药微调三号方联合香菇多糖组23例予中药微调三号方联合香菇多糖治疗,香菇多糖组24例予香菇多糖治疗。治疗2周后观察2组细胞免疫功能变化。结果中药微调三号方联合香菇多糖组治疗后自然杀伤(NK)细胞、CD3、CD4较本组治疗前升高(P<0.05),香菇多糖组治疗后CD3、CD4较本组治疗前降低(P<0.05)。中药微调三号方联合香菇多糖组治疗后NK低于香菇多糖组(P<0.05),CD4高于香茹多糖组(P<0.05)。中药微调三号方联合香菇多糖组治疗后中医证候积分低于本组治疗前(P<0.05),卡氏评分升高(P<0.05);中药微调三号方联合香菇多糖组治疗后中医证候积分低于香菇多糖组(P<0.05)。结论中药微调三号方联合香菇多糖较单用香菇多糖能有效提高中晚期胃癌患者CD3、CD4细胞比例,提高NK细胞水平,从而提高患者细胞免疫功能。 Objective To investigate the effect of combination of traditional Chinese medicine and lentinan on cellular immunity in patients with medium and advanced gastric cancer. Methods 47 patients with medium and advanced gastric cancer were randomly divided into two groups. Patients in lentinan group (n=24) were treated by lentinan. 23 cases in traditional Chinese medicine combined with lentinan group were treated by combination of traditional Chinese medicine and lentinan. The changes of cellular immunity were observed after two weeks.Results NK cell, CD3 and CD4 was increased compared with those before treatment in traditional Chinese medicine combined with lentinan group (P0.05). CD3 and CD4 was decreased compared with those before treatment in lentinan group (P0.05). NK was decreased, CD4 was increased compared with those in lentinan group after treatment (P0.05). Syndromes of traditional Chinese medicine score were decreased compared with those before treatment in traditional Chinese medicine combined with lentinan group (P0.05).Conclusion The combination of traditional Chinese medicine and lentinan can increase ratio of CD3 and CD4 in patients with medium and advanced gastric cancer, and raise NK cell for improvement of cellular immunity.
作者 倪依群
出处 《河北中医》 2010年第8期1136-1138,共3页 Hebei Journal of Traditional Chinese Medicine
关键词 胃肿瘤 免疫 中药疗法 Stomach neoplasms Immunization Traditional Chinese medicine therapy
  • 相关文献

参考文献3

二级参考文献19

  • 1HuiWan,MarcelDupasquier.Dendritic Cells in vivo and in vitro[J].Cellular & Molecular Immunology,2005,2(1):28-35. 被引量:17
  • 2郑莜萸主编.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.216-224.
  • 3孙传兴主编.I晦床疾病诊断治愈好转标准:第2版[M].北京:人民军医出版社,1998.63.
  • 4Paemans M, Sculier JP, Libert P, et al. Prognostic factors for survival in advanced non-small cell lung cancer: uni-and multivariate analysis including RECPAM in 1052 patients. J Clin Oncol 1995;13:1221-1230.
  • 5Rawson NSB, Peto J. An overview of prognostic factors in small cell lung cancer. A report from the subcommittee for the management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Reseach. Br J Cancer 1990;61:597-604.
  • 6Sagman U, Feld R, Evans WK, et al. The prognostic significance of pretrement serum lactate dehydrogenase in patients with small-cell lung cancer. J Clin Oneol 1991;9:954-961.
  • 7Osterlind K, Andersen PK. Prognostic factors in small cell lung cancer: multivariate moded based on 778 patients treated with chemotherapy with or without irradiation. Cancer Res 1986;46:4189-4194.
  • 8Brambilla C, Brambilla E. Lung Tumors, fundamental biology and clinical management. New York: Marcel Dekkerlnc,1999 : 157-171, 173-190, 211-225, 269-277, 347-364,365-382, 399-422, 423-433, 435-452, 583-593.
  • 9Ogawa J, Tsurumi T, Inoue H, et al. Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer. Cancer 1990;65:1391-1395.
  • 10Asiner J, Arriagada R, Green MR, et al. Comprehensive textbook of thoracic oneology. Baltimore: Williams & Wilkins, 1996: 25-35,276-292,319-335.

共引文献87

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部